This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: anthracycline

March 2009 Br J Cardiol 2009;16:60–2

Cardiotoxicity from cytotoxics in the 21st century

Rebecca Kristeleit, Mary O’Brien

Abstract

Cardiotoxicity and adjuvant anthracycline in early breast cancer Anthracycline-based polychemotherapy regimens for early-stage breast cancer have demonstrated a superior disease-free and overall survival in comparison to non-anthracycline based regimens.6 The increasing usage and efficacy of adjuvant chemotherapy is a significant factor contributing to the fall in mortality from breast cancer.6-9 However, the rising numbers of patients treated with anthracyclines in the adjuvant setting could mean that many women have sustained subclinical cardiac damage that is not yet clinically apparent. A recent analysis has attempted to define the exten

| Full text

March 2009 Br J Cardiol 2009;16:85-89

Current concepts of anthracycline cardiotoxicity: pathogenesis, diagnosis and prevention

Brad Pfeffer, Constantine Tziros, Richard J Katz

Abstract

(more…)

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now